Skip to main content

Primary Nav

About
Science & Technology
Patients
- Our Commitment
- Clinical Study Overview
Therapeutic Areas
Investors
Contact

Social Media Guidelines
Terms and Conditions
Newsletter Subscription

Breadcrumb

Home
Investors
Press Releases
challenges developing gene therapies rare eye diseases

Press Release

Site - IR Menu

Corporate Overview
Press Releases
Events and Presentations
Stock Information
Stock Quote & Chart Historic Price Lookup Analyst Coverage
Corporate Governance
SEC Filings
Resources
Investor FAQs Information Request Form Investor Contacts

Challenges in Developing Gene Therapies for Rare Eye Diseases

June 2, 2020

Challenges in Developing Gene Therapies for Rare Eye Diseases 1.3 MB

Sign up to receive email alerts with the latest news from Ocugen

Stay Connected

Contact us for more information

Courageous
Innovation.

CONNECT LinkedIn Twitter

11 Great Valley Parkway Malvern, PA 19355 484.328.4701

CONTACT US

Tiffany Hamilton
Head of Communications
IR@ocugen.com

Footer Copyright Links Terms and Conditions | Social Media Guidelines |

© 2024 Ocugen, Inc. | All Rights Reserved